Clinical Trial Update: Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma [Phase 3]

View source ↗

Summary

Extension study assessing long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma; completed with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2023-02-09